Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101041638B reveals novel metal-free chiral amines. Discover cost-effective synthesis and high-purity supply for asymmetric catalysis applications.
Patent CN103694217A reveals a catalyst-free route for 2,4-disubstituted thiophenes using K2S, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Novel Cu-catalyzed route for benzothienothiazole derivatives offering cost-effective manufacturing and stable supply for electronic and pharma applications.
Patent CN118290429B enables high-yield Fezolinetant intermediate synthesis with improved chiral purity and scalable manufacturing processes for global supply chains.
Patent CN115925651B enables green photochemical synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN106543144A reveals a safer industrial process for Dabigatran Etexilate. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable solutions.
Novel pyridazinone-containing norcantharidin derivative synthesis via 1,3-dipolar cycloaddition. Offers high purity pharmaceutical intermediates with optimized supply chain reliability.
Patent CN117263870A details high-yield Resmetirom intermediate III synthesis with reduced cost and environmental impact for global pharmaceutical supply chains.
Novel electrochemical method replaces gold catalysts for trans-olefin production. High purity, room temperature process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel Cu-catalyzed method for Tazobactam Sodium synthesis. Delivers safer, scalable, and cost-effective production solutions for global pharmaceutical supply chains and procurement teams.
Patent CN105906649B details asymmetric synthesis of chiral spirolides. Offers high stereoselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN107721984A enables high-yield triazole synthesis. Offers cost reduction in pharma manufacturing and reliable supply chain for API intermediates.
Novel synthetic route for 8-azacoumarins offering high yield and solubility for pharma supply chains. Scalable process from patent CN106810560A.
Patent CN111484533B discloses novel Ir-SpiroPNP catalysts achieving 99.8% ee in dialkyl ketone hydrogenation, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN117603100B reveals a green one-pot synthesis route offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN111138492B details a high-yield Brigatinib synthesis avoiding column chromatography. This report analyzes cost reduction and supply chain reliability for API manufacturing.
Patent CN104817484A reveals metal-free 2-indolone synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102010455B reveals a novel Decitabine synthesis avoiding isomer separation. High purity >99.85% via Barton-McCombie deoxygenation for cost-effective manufacturing.
Patent CN108586211B reveals a cost-effective Pd-catalyzed decarboxylative coupling method for 1,1-diarylethene derivatives, offering significant supply chain advantages.
Patent CN101302191B details a high-yield Vilsmeier cyclization for 3-formyl-4-halopyridin-2-ones, offering cost-effective manufacturing and reliable supply chain solutions.